S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
LON:EMIS

EMIS Group (EMIS) Share Forecast, Price & News

GBX 1,360
+4.00 (+0.29%)
(As of 06/9/2023 ET)
Compare
Today's Range
1,336
1,367.20
50-Day Range
1,320
1,651.01
52-Week Range
1,250
1,918
Volume
67,498 shs
Average Volume
714,430 shs
Market Capitalization
£861.02 million
P/E Ratio
2,615.38
Dividend Yield
2.87%
Price Target
N/A

EMIS stock logo

About EMIS Group (LON:EMIS) Stock

EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web, which enables patients to order repeat medication online and track progress from order to home delivery; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.

Receive EMIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EMIS Group and its competitors with MarketBeat's FREE daily newsletter.

EMIS Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
EMIS Group plc (EMIS) To Go Ex-Dividend on June 15th
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Jet Capital Investors LP - Form 8.3 - EMIS Group Plc
Palliser Capital (UK) Ltd - Form 8.3 - EMIS Group Plc
BOE's March 23 Rate Decision is Finely Balanced
FTSE 100 Rises as Banking Sector Fears Ease
Form 8.3 - EMIS Group plc - Amendment
Rule 8.3 -Emis Group Plc
See More Headlines

EMIS Price History

EMIS Company Calendar

Last Earnings
3/14/2018
Today
6/09/2023
Ex-Dividend for 7/11 Dividend
6/15/2023
Dividend Payable
7/11/2023

Industry, Sector and Symbol

Industry
Technical & System Software
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,429
Year Founded
N/A

Profitability

Net Income
£33.17 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£175.37 million
Cash Flow
GBX 61.91 per share
Book Value
GBX 225 per share

Miscellaneous

Free Float
N/A
Market Cap
£858.48 million
Optionable
Not Optionable
Beta
-0.07

Key Executives

  • Mr. Andrew John Thorburn (Age 60)
    CEO & Exec. Director
    Comp: $1.06M
  • Mr. Peter J. Southby (Age 49)
    CFO & Exec. Director
    Comp: $703k
  • Mr. David Gibbons
    Chief Operating Officer
  • Mr. Richard Jarvis
    Chief Technology Officer
  • Ms. Jacqui Summons
    Group HR Director
  • Dr. Shaun O'Hanlon (Age 57)
    Chief Medical Officer
  • Mr. Paul Lowry
    Group Chief Engineer
  • Ms. Suzy Foster
    Chief Exec. Officer of EMIS Health & EMIS Enterprise
  • Pankaj Mistry
    Chief Information Security Officer
  • Christine Benson
    Company Sec.













EMIS Stock - Frequently Asked Questions

How have EMIS shares performed in 2023?

EMIS Group's stock was trading at GBX 1,872 at the beginning of 2023. Since then, EMIS shares have decreased by 27.6% and is now trading at GBX 1,356.
View the best growth stocks for 2023 here
.

How were EMIS Group's earnings last quarter?

EMIS Group plc (LON:EMIS) issued its quarterly earnings data on Wednesday, March, 14th. The company reported $47.20 earnings per share for the quarter, topping analysts' consensus estimates of $46.30 by $0.90. The company earned $160.35 million during the quarter. EMIS Group had a net margin of 18.91% and a trailing twelve-month return on equity of 24.48%.

How often does EMIS Group pay dividends? What is the dividend yield for EMIS Group?

EMIS Group declared a dividend on Thursday, May 25th. Investors of record on Thursday, June 15th will be paid a dividend of GBX 21.10 per share on Tuesday, July 11th. This represents a dividend yield of 1.59%. The ex-dividend date of this dividend is Thursday, June 15th. This is a positive change from the stock's previous dividend of GBX 17.60. The official announcement can be viewed at this link.
Read our dividend analysis for EMIS
.

Is EMIS Group a good dividend stock?

EMIS Group (LON:EMIS) pays an annual dividend of GBX 39 per share and currently has a dividend yield of 2.88%. The dividend payout ratio is 7,500.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for EMIS.

What other stocks do shareholders of EMIS Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other EMIS Group investors own include RM (RM), Shire (SHP), The Character Group (CCT), Babcock International Group (BAB), Croda International (CRDA), James Halstead (JHD), Micro Focus International (MCRO), Nichols (NICL), Poundland Group (PLND) and Renew (RNWH).

What is EMIS Group's stock symbol?

EMIS Group trades on the London Stock Exchange (LON) under the ticker symbol "EMIS."

How do I buy shares of EMIS Group?

Shares of EMIS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is EMIS Group's stock price today?

One share of EMIS stock can currently be purchased for approximately GBX 1,356.

How much money does EMIS Group make?

EMIS Group (LON:EMIS) has a market capitalization of £858.48 million and generates £175.37 million in revenue each year. The company earns £33.17 million in net income (profit) each year or GBX 0.52 on an earnings per share basis.

How many employees does EMIS Group have?

The company employs 1,429 workers across the globe.

How can I contact EMIS Group?

EMIS Group's mailing address is Rawdon House, Green Lane, LEEDS, LS19 7BY, United Kingdom. The official website for the company is www.emisgroupplc.com. The company can be reached via phone at +44-113-3803000.

This page (LON:EMIS) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -